Articles with public access mandates - Elise LandaisLearn more
Available somewhere: 46
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
TF Rogers, F Zhao, D Huang, N Beutler, A Burns, W He, O Limbo, C Smith, ...
Science 369 (6506), 956-963, 2020
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Human circulating PD-1+ CXCR3− CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses
M Locci, C Havenar-Daughton, E Landais, J Wu, MA Kroenke, ...
Immunity 39 (4), 758-769, 2013
Mandates: US National Institutes of Health
Structural basis of a shared antibody response to SARS-CoV-2
M Yuan, H Liu, NC Wu, CCD Lee, X Zhu, F Zhao, D Huang, W Yu, Y Hua, ...
Science 369 (6507), 1119-1123, 2020
Mandates: US Department of Energy, Bill & Melinda Gates Foundation, US National …
CXCL13 is a plasma biomarker of germinal center activity
C Havenar-Daughton, M Lindqvist, A Heit, JE Wu, SM Reiss, K Kendric, ...
Proceedings of the National Academy of Sciences 113 (10), 2702-2707, 2016
Mandates: US National Institutes of Health
Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort
E Landais, X Huang, C Havenar-Daughton, B Murrell, MA Price, ...
PLoS pathogens 12 (1), e1005369, 2016
Mandates: US National Institutes of Health
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses
JM Steichen, YC Lin, C Havenar-Daughton, S Pecetta, G Ozorowski, ...
Science 366 (6470), eaax4380, 2019
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
MJ Van Gils, TLGM Van Den Kerkhof, G Ozorowski, CA Cottrell, D Sok, ...
Nature microbiology 2 (2), 1-10, 2016
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health …
Early antibody lineage diversification and independent limb maturation lead to broad HIV-1 neutralization targeting the Env high-mannose patch
DT MacLeod, NM Choi, B Briney, F Garces, LS Ver, E Landais, B Murrell, ...
Immunity 44 (5), 1215-1226, 2016
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health …
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen
C Havenar-Daughton, A Sarkar, DW Kulp, L Toy, X Hu, I Deresa, ...
Science translational medicine 10 (448), eaat0381, 2018
Mandates: US Department of Energy, Bill & Melinda Gates Foundation, US National …
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
E Landais, PL Moore
Retrovirology 15, 1-14, 2018
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, US Agency …
Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding
L He, D Sok, P Azadnia, J Hsueh, E Landais, M Simek, WC Koff, ...
Scientific reports 4 (1), 6778, 2014
Mandates: US National Institutes of Health, Department of International Development, UK
HIV envelope glycoform heterogeneity and localized diversity govern the initiation and maturation of a V2 apex broadly neutralizing antibody lineage
E Landais, B Murrell, B Briney, S Murrell, K Rantalainen, ZT Berndsen, ...
Immunity 47 (5), 990-1003. e9, 2017
Mandates: US Department of Energy, Bill & Melinda Gates Foundation, US National …
Immunogenicity of RNA replicons encoding HIV Env immunogens designed for self-assembly into nanoparticles
M Melo, E Porter, Y Zhang, M Silva, N Li, B Dobosh, A Liguori, P Skog, ...
Molecular Therapy 27 (12), 2080-2090, 2019
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, US Agency …
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
D Huang, JT Tran, A Olson, T Vollbrecht, M Tenuta, MV Guryleva, ...
Nature communications 11 (1), 5850, 2020
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation
E Landais, PA Romagnoli, AL Corper, J Shires, JD Altman, IA Wilson, ...
The Journal of Immunology 183 (12), 7949-7957, 2009
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Rapid and focused maturation of a VRC01-class HIV broadly neutralizing antibody lineage involves both binding and accommodation of the N276-glycan
J Umotoy, BS Bagaya, C Joyce, T Schiffner, S Menis, KL Saye-Francisco, ...
Immunity 51 (1), 141-154. e6, 2019
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, US Agency …
Scavenger receptors target glycolipids for natural killer T cell activation
S Freigang, E Landais, V Zadorozhny, L Kain, K Yoshida, Y Liu, S Deng, ...
The Journal of clinical investigation 122 (11), 3943-3954, 2012
Mandates: Swiss National Science Foundation, US National Institutes of Health
An MPER antibody neutralizes HIV-1 using germline features shared among donors
L Zhang, A Irimia, L He, E Landais, K Rantalainen, DP Leaman, ...
Nature communications 10 (1), 5389, 2019
Mandates: US Department of Energy, Bill & Melinda Gates Foundation, US National …
Co-evolution of HIV envelope and apex-targeting neutralizing antibody lineage provides benchmarks for vaccine design
K Rantalainen, ZT Berndsen, S Murrell, L Cao, O Omorodion, JL Torres, ...
Cell reports 23 (11), 3249-3261, 2018
Mandates: US Department of Energy, Bill & Melinda Gates Foundation, US National …
Profiling human antibody responses by integrated single-cell analysis
AO Ogunniyi, BA Thomas, TJ Politano, N Varadarajan, E Landais, ...
Vaccine 32 (24), 2866-2873, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program